IMS Group Updates Board Structure: Dr. Wilson Lee to Step Down, Mr. Lo King Shun Returns as Independent Director and Remuneration Chair

Bulletin Express
09/01

IMS Group Holdings Limited (IMS Group, 08136) announced a planned reshuffle of its board of directors, effective 1 September 2026.

Dr. Wilson Lee will resign as Independent Non-Executive Director (INED) after more than eight years of service, enabling the company to remain compliant with GEM Listing Rules that discourage independent directorships exceeding nine years. Concurrently, he will relinquish his roles as Chairman of the Remuneration Committee and member of both the Nomination and Audit Committees. Dr. Lee confirmed no outstanding claims against the company and reported no disagreements with the board.

Succeeding Dr. Lee, the board has appointed former executive director Mr. Lo King Shun as INED, effective the same day. Mr. Lo, aged 64, brings over 16 years of project-management experience within the Group’s lighting and audiovisual businesses. His prior roles include Senior Manager positions at IMS Group subsidiaries and a tenure as Executive Director from January 2020 to July 2024. Under his new three-year term, he will serve as: • Chairman, Remuneration Committee • Member, Nomination Committee • Member, Audit Committee

Mr. Lo will receive an annual director’s fee of HK$0.18 million, a level the board states reflects his responsibilities and market benchmarks. The company affirmed Mr. Lo’s independence per Rule 5.09 of the GEM Listing Rules, noting zero shareholding in IMS Group and no ties to major shareholders, directors, or connected persons.

Post-change, IMS Group’s board will comprise two executive directors—Mr. Tam Yat Ming Andrew (Chairman and CEO) and Ms. Fok Yee Man—alongside three INEDs: Mr. Li Chun Hung, Mr. Ha Yiu Wing and Mr. Lo King Shun. The board expressed appreciation for Dr. Lee’s contributions and welcomed Mr. Lo’s return in an independent capacity.

These moves conclude IMS Group’s phased compliance with Hong Kong’s corporate governance guidelines on INED tenure while strengthening oversight through refreshed committee leadership.

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10